Similar Articles
Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease
Ayhan ÖZTÜRK, Hilmi UYSAL
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
P300 and P300 Topographic Mapping in Parkinson's Disease
Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
COVID-19-associated Leukoencephalopathy Involving the Splenium of the Corpus Callosum
Özlem Kayım Yıldız, Bülent Yıldız, Mürşit Hasbek, Gülsüm Aslı Tatlı, Murtaza Öz
DOI: 10.4274/tnd.2021.38445
Epigenetic analysis of heat shock activator complex in the peripheral blood of Parkinson's disease patients and its clinical significance
Yagmur İnalkac Gemici, Irem Tasci, Muhammed Dundar, Nazmi Ozgen, Nefsun Danis, Harika Gozde Gozukara, Ahmet Koc
DOI: 10.55697/tnd.2024.110
Impact of a 12-week structured exercise program on motor function and exosomal alpha-synuclein levels in Parkinson's disease: A prospective analysis
Nihat Mustafayev, Abdulkadir Tunç, Birsen Elibol, Kamer Unal Eren, Sule Terzioglu-Usak
DOI: 10.55697/tnd.2024.8
Impulse control disorders related cognitive and behavioral features in Parkinson’s disease
Esra Erkoc Ataoglu, Yasemin Bozdağ, Ayse Bora Tokcaer
DOI: 10.55697/tnd.2024.109
Scale consistance in cognitive status awareness of patients with Parkinson’s disease
Sabiha Tezcan Aydemir, Elif Yüsra Unutmaz, Pınar Özkan, Talha Abalı, Gülnur Ayık, Dudu Genç Batmaz, Sema Nur Kibrit, Ahmet Veli Karacan, Müge Kuzu Kumcu, Merve Koç Yekedüz, Fatma Tuba Eminoğlu, Rezzak Yılmaz, Muhittin Cenk Akbostancı
DOI: 10.55697/tnd.2024.139